Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating daily tadalafil 5 mg plus on-demand sildenafil 100 mg for erectile dysfunction in patients who do not respond to PDE-5 inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)
  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Mansoura University | Conditions: Erectile Dysfunctions | Phase 4 | Status: RECRUITING